Results 201 to 210 of about 81,723 (303)

Topical JAK (Janus Kinase) Inhibitor Therapy for Chronic External Otitis in Atopic Dermatitis: A Case Report. [PDF]

Cureus
Hirano K, Hirano Y, Yu M, Tei Y, Shimane T.   +4 more
europepmc   +1 more source

Multilingual Digital Search Behavior Reveals Cultural Disparities in Vitiligo Information Needs in Germany

International Journal of Dermatology, EarlyView.
Multilingual vitiligo‐related Google search queries in Germany (October 2019–May 2023) were extracted and thematically coded across German, English, Turkish, Arabic, Russian, and Polish. Relative patterns highlighted language‐specific emphases in treatment information, camouflage, depigmentation, psychosocial burden, and faith/home‐remedy terms ...
Lilian Rauch, Christine Gasteiger, Markus Böhm, Georg Pliszewski, Tilo Biedermann, Alexander Zink   +5 more
wiley   +1 more source

Acute graft versus host disease postliver transplant with mucocutaneous manifestations and pancytopenia: Remission with Janus kinase inhibitor. [PDF]

JAAD Case Rep
Mendoza R, Liu L, Sam A, Abdel-Azim H, Greas M, Dao H.   +5 more
europepmc   +1 more source

Iron Overload: Pathophysiology, Diagnosis and Monitoring

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Iron overload is associated with significant health risks, underscoring the importance of understanding its pathophysiology as well as establishing accurate diagnostic and monitoring methods. Chronic iron overload is associated with either genetic disorders characterized by excessive iron accumulation (hereditary hemochromatosis), or is ...
Elena Chatzikalil, Polyxeni Delaporta, Konstantinos Bistas, Antonis Kattamis   +3 more
wiley   +1 more source

Ruxolitinib cream for the treatment of granuloma annulare

JAAD Case Reports
Austin J. Piontkowski, BS, Nancy Wei, MD, Aisha Mumtaz, MD, Nicholas Gulati, MD, PhD   +3 more
doaj   +1 more source

Janus kinase inhibitor treatment for inflammatory diseases: excess or no excess risk of venous thromboembolism? [PDF]

Res Pract Thromb Haemost
Dawudi Y, Benarroch S, Helfer H, Smadja DM, Mahé I.   +4 more
europepmc   +1 more source

Two decades of biologic and JAK inhibitor prescription patterns in the western region of Melbourne

Internal Medicine Journal, EarlyView.
Abstract Background and Aim Safety concerns and medication shortages may influence prescribing practices in rheumatology. This study aimed to explore the impact of Janus kinase inhibitor (JAKi) safety warnings and the COVID‐19 pandemic on biologic and targeted‐synthetic disease‐modifying antirheumatic drug (b/tsDMARD) prescription patterns from 2002 to
Alexander Kwan, Elvina Ingrid, Sara Vogrin, Ken Luong, Fei Jin, Emma Brown, Dongzhe Li, Matthew Jiang, Keith K. T. Lim   +8 more
wiley   +1 more source

Bone Mineral Density During Treatment with The Janus Kinase Inhibitor Baricitinib in Patients with Rheumatoid Arthritis: A Monocentric Observational Study. [PDF]

Calcif Tissue Int
Schulz N, Asendorf T, van Wijnen P, Wilhelmi T, Müller-Ladner U, Lange U, Klemm P.   +6 more
europepmc   +1 more source

AKT/eNOS signaling module functions as a potential feedback loop in the growth hormone signaling pathway [PDF]

, 2009
Cong-Jun Li, Theodore H Elsasser, Stanislaw Kahl   +2 more
core   +1 more source

JAK inhibitors and menstrual cycle alterations: insights from a case series of 16 female patients

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Luciano Ibba, Luigi Gargiulo, Matteo Bianco, Sara Di Giulio, Ruggero Cascio Ingurgio, Angela Alfano, Carlo A. Vignoli, Mario Valenti, Paola Facheris, Chiara Perugini, Alessandra Narcisi, Antonio Costanzo   +11 more
wiley   +1 more source